Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Powis

Showing results (31-40 of 261) with videos related to

Pageof 27
Sort By:
Anti-Cancer Drug Design|December 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Clinical Biochemistry|October 1, 1991
Growth factor and oncogene signalling pathways as targets for rational anticancer drug developmentG Powis, A Kozikowski
Biochemical Pharmacology|February 1, 1980
Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450G Powis, L Wincentsen
Biochemical Pharmacology|October 1, 1976
The effect of inhibitors of alcohol metabolism upon the changes in the hepatic microsomal metabolism of foreign compounds produced by the acute administration of some alcohols to the ratG Powis, L Grant
The Biochemical Journal|February 5, 2000
Thioredoxin reductaseD Mustacich, G Powis
Anti-Cancer Drug Design|August 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Pharmacology & Therapeutics|January 1, 1979
Stoichiometry of the mixed function oxidaseG Powis, I Jansson
Cancer Chemotherapy and Pharmacology|January 1, 1988
Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductaseJ J Schlager, G Powis
Annual Review of Pharmacology and Toxicology|March 27, 2001
Properties and biological activities of thioredoxinsG Powis, W R Montfort
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Inhibiting intracellular signalling as a strategy for cancer chemopreventionG Powis, D S Alberts
Pageof 27

Showing results (31-40 of 261) with videos related to

Sort By:
Pageof 27
Anti-Cancer Drug Design|December 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Clinical Biochemistry|October 1, 1991
Growth factor and oncogene signalling pathways as targets for rational anticancer drug developmentG Powis, A Kozikowski
Biochemical Pharmacology|February 1, 1980
Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450G Powis, L Wincentsen
Biochemical Pharmacology|October 1, 1976
The effect of inhibitors of alcohol metabolism upon the changes in the hepatic microsomal metabolism of foreign compounds produced by the acute administration of some alcohols to the ratG Powis, L Grant
The Biochemical Journal|February 5, 2000
Thioredoxin reductaseD Mustacich, G Powis
Anti-Cancer Drug Design|August 1, 1994
Signalling targets for the development of cancer drugsG Powis, P Workman
Pharmacology & Therapeutics|January 1, 1979
Stoichiometry of the mixed function oxidaseG Powis, I Jansson
Cancer Chemotherapy and Pharmacology|January 1, 1988
Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductaseJ J Schlager, G Powis
Annual Review of Pharmacology and Toxicology|March 27, 2001
Properties and biological activities of thioredoxinsG Powis, W R Montfort
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Inhibiting intracellular signalling as a strategy for cancer chemopreventionG Powis, D S Alberts
Pageof 27